New drug price law could help Part D en­rollees who can't fill can­cer treat­ments due to costs, White House says

The White House’s Coun­cil of Eco­nom­ic Ad­vi­sors said late last week that health cov­er­age can come in unique ways, such as with new­ly passed fed­er­al leg­is­la­tion, the In­fla­tion Re­duc­tion Act. And in cit­ing new da­ta, it re­veals some in­sights in­to can­cer pa­tients, a key em­pha­sis for the Biden Ad­min­is­tra­tion thanks to Pres­i­dent Biden’s re­vived Can­cer Moon­shot.

In a blog post pub­lished Fri­day, the White House high­light­ed re­duc­ing pre­scrip­tion drug costs for Medicare ben­e­fi­cia­ries as one of three ways it sees ac­cess to health­care in­creas­ing. The IRA specif­i­cal­ly caps out-of-pock­et costs for se­niors at $2,000 a year, in ad­di­tion to grant­i­ng Medicare the au­thor­i­ty to ne­go­ti­ate drug prices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.